Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step? Khasraw M, Dun MD, Arrillaga-Romany I, Verhaak RGW, et al. Neuro Oncol 2026 May 22:noag117. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Khasraw M, Dun MD, Arrillaga-Romany I, Verhaak RGW, et al. Dordaviprone for Diffuse Midline Glioma: A Landmark Approval or a Premature Step? Neuro Oncol 2026 May 22:noag117. doi: 10.1093.
PMID: 42172613